26.3 Antidiuretic Hormones

Antidiuretic Hormone (ADH) Medications

ADH medications are synthetic versions of vasopressin, the hormone your posterior pituitary gland releases to regulate water balance. When vasopressin is deficient or absent, the kidneys can't concentrate urine, leading to massive fluid loss. These drugs replace that missing signal, and nurses play a central role in monitoring their effects and preventing dangerous complications like hyponatremia.

Key Features and Therapeutic Uses

The most commonly prescribed ADH medication is desmopressin (DDAVP), a synthetic analog of vasopressin. It's available as an intranasal spray, oral tablet, or injectable solution.

Therapeutic uses include:

• Central diabetes insipidus (CDI): The primary indication. CDI occurs when the posterior pituitary doesn't produce enough ADH, causing massive urine output (sometimes 10–20 liters/day) and extreme thirst. Desmopressin replaces the missing hormone.
• Nocturnal enuresis: Used in children for bedwetting when other interventions haven't worked. The drug reduces overnight urine production.
• Hemophilia A and von Willebrand disease: Desmopressin stimulates the release of factor VIII and von Willebrand factor from endothelial cells, temporarily improving clotting ability. This is a separate use from its antidiuretic effect.

Mechanism of Action, Side Effects, and Drug Interactions

How it works: Desmopressin binds to V2 receptors on the collecting ducts of the kidneys. This triggers insertion of aquaporin-2 water channels into the duct membrane, increasing water permeability. The result: more water is reabsorbed back into the bloodstream, urine becomes concentrated, and urine volume drops.

Side effects:

• Hyponatremia is the most serious risk. When too much water is retained, serum sodium gets diluted. Mild cases cause headache, nausea, and confusion. Severe hyponatremia can progress to seizures and coma.
• Headache, nausea, and abdominal cramps (common, usually mild)
• Nasal congestion or nosebleeds with intranasal formulations
• Allergic reactions (rash, itching) are uncommon but possible

Drug interactions to watch for:

• Drugs that also lower sodium increase hyponatremia risk: thiazide diuretics, SSRIs, carbamazepine, and tricyclic antidepressants. If your patient is on any of these, sodium monitoring becomes even more critical.
• NSAIDs can enhance the antidiuretic effect of desmopressin (by reducing renal prostaglandins), which paradoxically raises the risk of water retention and hyponatremia.

Essential Nursing Considerations

Assessment:

1. Obtain baseline vital signs, body weight, and serum sodium level before starting therapy.
2. Monitor strict intake and output (I&O). In CDI patients, you're looking for urine output to decrease toward a normal range.
3. Assess for signs of hyponatremia at every encounter: confusion, headache, nausea, muscle cramps, lethargy.

Administration:

1. Verify the route (intranasal, oral, or IV/subcutaneous) and confirm the dose. Dosing varies significantly by indication.
2. For intranasal administration, teach the patient to prime the spray pump before first use and to alternate nostrils to reduce irritation.
3. Oral tablets should be taken on an empty stomach when possible, as food can reduce absorption.

Ongoing monitoring:

• Check serum sodium levels regularly, especially during dose adjustments and in elderly patients (who are more susceptible to hyponatremia).
• Weigh the patient daily. A rapid weight gain suggests excessive water retention.
• Adjust dosing based on urine output, urine specific gravity, and sodium levels. Report significant changes to the provider.

Patient Education

• Why you're taking this medication: Explain that the drug replaces a hormone the body isn't making enough of, helping the kidneys hold onto water instead of losing it as dilute urine.
• How to take it correctly: Demonstrate intranasal technique if applicable. Stress the importance of consistent dosing and not doubling up on missed doses.
• Fluid balance matters: Patients should drink only when thirsty and avoid excessive fluid intake, especially in the evening (to reduce hyponatremia risk). This is particularly important for children taking it for bedwetting.
• Know the warning signs: Teach patients and caregivers to recognize hyponatremia symptoms: persistent headache, nausea, confusion, muscle cramps, or unusual drowsiness. These require prompt medical attention.
• Report changes: Patients should track urine output and notify their provider if output increases significantly (suggesting the medication isn't working) or if they notice rapid weight gain or swelling.
• Medication interactions: Remind patients to inform all providers about their desmopressin use, especially before starting new medications, supplements, or OTC drugs like ibuprofen.